Osteosarcoma: Clinical Trials

12 trials for Osteosarcoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 unknown. 12 Phase 1, 8 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 112Unknown 12
Phase 28Unknown 8

Follow Osteosarcoma: new trials by email Literature Review of Osteosarcoma trials Research Report on Osteosarcoma

Trials (filtered) newest first · largest first

All 12 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
IM83 Clinical Study of CAR-T Cell Therapy in Patients With Relapsed or Refractory Osteosarcoma
IM83 CAR-T Cells - Refractory Osteosarcoma, Recurrent Osteosarcoma
Phase 1UnknownBeijing Immunochina Medical Science & Technology Co., Ltd.92024-06-152024-05-14
A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577)
Seclidemstat - Ewing Sarcoma, Myxoid Liposarcoma
Phase 1 / Phase 2UnknownSalarius Pharmaceuticals, LLC102022-01-152023-08-01
A Study to Evaluate the Safety and Efficacy of ALMB-0168 in Patients With Osteosarcoma
ALMB-0168 - Osteosarcoma
Phase 1 / Phase 2UnknownAlaMab Therapeutics (Shanghai) Inc.2382021-05-012021-05-14
TQB3525 for Advanced Bone Sarcomas With PI3KA Mutations or PTEN Loss
TQB3525 - Safety Issues, Efficacy, Self
Phase 1 / Phase 2UnknownPeking University People's Hospital292020-10-012020-12-31
A Phase I Clinical Trial of Neoadjuvant Chemotherapy With/Without SPIONs/SMF for Patients With Osteosarcoma
neoadjuvant chemotherapy+SPIONs/SMF, neoadjuvant chemotherapy - Osteosarcoma
Phase 1UnknownSecond Affiliated Hospital, Zhejiang University, School of Medicine602020-09-012020-03-20
A Clinical Study of PD-L1 Antibody ZKAB001(Drug Code) in Limited Stage of High-grade Osteosarcoma
ZKAB001 5mg/kg, ZKAB001 10mg/kg, ZKAB001 15mg/kg - Osteosarcoma
Phase 1 / Phase 2UnknownLee's Pharmaceutical Limited152018-10-102018-09-26
Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas
Seclidemstat, Cyclophosphamide, Topotecan - Ewing Sarcoma, Myxoid Liposarcoma
Phase 1UnknownSalarius Pharmaceuticals, LLC502018-06-042023-11-21
Anlotinib and Irinotecan for Ewing Sarcoma
Anlotinib, Irinotecan - Ewing's Tumor Metastatic
Phase 1 / Phase 2UnknownPeking University People's Hospital472018-01-222019-02-15
Pilot Study of Expanded , Activated Haploidentical Natural Killer Cell Infusions for Sarcomas
Expanded , Activated NK cells - Ewing Sarcoma, Rhabdomyosarcoma
Phase 1 / Phase 2UnknownNational University Hospital, Singapore202015-02-012019-04-16
Pilot Study of Curcumin Formulation and Ashwagandha Extract in Advanced Osteosarcoma
Curcumin powder, Ashwagandha extract - Osteosarcoma
Phase 1 / Phase 2UnknownTata Memorial Hospital242008-05-012011-06-23
Safety Study of Seneca Valley Virus in Patients With Solid Tumors With Neuroendocrine Features
Seneca Valley Virus (biological agent) - Carcinoid, Neuroendocrine
Phase 1UnknownNeotropix602006-04-012010-02-25
Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors
High-Dose Chemotherapy with Tandem PBSC Rescue. - Ewing's Sarcoma, Soft Tissue Sarcoma
Phase 1 / Phase 2UnknownAnn & Robert H Lurie Children's Hospital of Chicago121999-04-012010-10-11

Narrower conditions

Sarcoma, Ewing (7)  ·  Chondrosarcoma, Extraskeletal Myxoid (2)  ·  Desmoplastic Small Round Cell Tumor (2)  ·  Histiocytoma, Angiomatoid Fibrous (2)  ·  Liposarcoma, Myxoid (2)  ·  Myoepithelioma (2)  ·  Rhabdomyosarcoma (2)  ·  Sarcoma (2)  ·  Sarcoma, Clear Cell (2)  ·  Wilms Tumor (2)  ·  Carcinoid Tumor (1)  ·  Chondrosarcoma (1)  ·  Fibroma (1)  ·  Glioblastoma (1)

Broader conditions

Neoplasms (12)  ·  Neoplasms by Histologic Type (12)  ·  Neoplasms, Bone Tissue (12)  ·  Neoplasms, Connective Tissue (12)  ·  Neoplasms, Connective and Soft Tissue (12)  ·  Sarcoma (10)  ·  Neoplasms, Complex and Mixed (4)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Genetic Diseases, Inborn (2)  ·  Kidney Diseases (2)  ·  Kidney Neoplasms (2)  ·  Liposarcoma (2)

Interventions

Cyclophosphamide (3)  ·  Topotecan (2)  ·  seclidemstat (2)  ·  Ashwagandha (1)  ·  Biological Factors (1)  ·  Drug Therapy (1)  ·  Irinotecan (1)  ·  Neoadjuvant Therapy (1)  ·  TQ-B3525 (1)  ·  anlotinib (1)

Sponsors

Peking University People's Hospital (2)  ·  Salarius Pharmaceuticals, LLC (2)  ·  AlaMab Therapeutics (Shanghai) Inc. (1)  ·  Ann & Robert H Lurie Children's Hospital of Chicago (1)  ·  Beijing Immunochina Medical Science & Technology Co., Ltd. (1)  ·  Lee's Pharmaceutical Limited (1)  ·  National University Hospital, Singapore (1)  ·  Neotropix (1)  ·  Second Affiliated Hospital, Zhejiang University, School of Medicine (1)  ·  Tata Memorial Hospital (1)

Countries

China (4)  ·  United States (4)  ·  India (1)  ·  Singapore (1)

Top investigators

Bernice Oh (1)  ·  Dario Campana (1)  ·  Jingnan Shen, Doctor (1)  ·  Morris Kletzel, M.D. (1)  ·  Rudin Charles, MD, PhD (1)  ·  Wei Guo, M.D, Ph.D (1)  ·  Wei Guo, Ph.D and M.D. (1)  ·  Yu Zhang, PhD (1)

Results publications

PMID 18391430, PMID 31401903, PMID 34941047, PMID 41685666